Skip to main content
Isuru Jayaratna, MD, Urology, New York, NY

IsuruSampathJayaratnaMD

Urology New York, NY

Minimally Invasive Surgery, Surgical Oncology

Urologic Oncologist

Dr. Jayaratna is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Jayaratna's full profile

Already have an account?

  • Office

    5 E 98th St
    Fl 6
    New York, NY 10029
    Phone+1 212-659-5559
    Fax+1 212-987-4675

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2014 - 2016
  • University of Southern California/Los Angeles General Medical Center (USC/LA General)
    University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Urology, 2009 - 2014
  • University of Southern California/Los Angeles General Medical Center (USC/LA General)
    University of Southern California/Los Angeles General Medical Center (USC/LA General)Internship, Surgery, 2008 - 2009
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 2008

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2010 - Present
  • NY State Medical License
    NY State Medical License 2016 - 2026
  • TX State Medical License
    TX State Medical License 2015 - 2019
  • American Board of Urology Urology

Publications & Presentations

PubMed

Journal Articles

  • An Evaluation of Race, Ethnicity, Age, and Sex-Based Representation in Phase I to II Renal Cell Carcinoma Clinical Trials in the United States  
    Isuru Jayaratna, John P Sfakianos, Ketan K Badani, Urologic Oncology

Authored Content

  • An Evaluation of Race, Ethnicity, Age, and Sex-Based Representation in Phase I to II Renal Cell Carcinoma Clinical Trials in the United StatesJune 2018

Research History

  • Urologic Oncology Research FellowGenomic research as part of the MD Anderson Bladder Cancer SPORE. Studied bladder cancer molecular subtypes using in vitro and xenograft in vivo models.2014 - 2015

Professional Memberships

Other Languages

  • Spanish